【结 构 式】 |
【分子编号】25385 【品名】tert-butyl 4-(2-methoxy-5-nitrophenyl)-1-piperazinecarboxylate 【CA登记号】 |
【 分 子 式 】C16H23N3O5 【 分 子 量 】337.37584 【元素组成】C 56.96% H 6.87% N 12.46% O 23.71% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)Nitration of 1-(2-methoxyphenyl)piperazine (I) using KNO3 in H2SO4 gave (II). After protection of (II) as the N-Boc derivative (III), reduction of the nitro group by catalytic hydrogenation over Pd/C yielded aniline (IV). This was condensed with 5-chloro-3-methylbenzothiophene-2-sulfonyl chloride (V) to afford the corresponding sulfonamide (VI). Finally, the Boc protecting group of (VI) was removed with HCl in boiling THF.
【1】 Bromidge, S.M.; Brown, A.M.; Clarke, S.E.; Dodgson, K.; Gager, T.; Grassam, H.L.; Jeffrey, P.M.; Joiner, G.F.; King, F.D.; Middlemiss, D.N.; Moss, S.F.; Newman, H.; Riley, G.; Routledge, C.; Wyman, P.; 5-Chloro-N-(4-methoxy-3-piperazin-1-ylphenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): A potent, selective, and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 1999, 42, 2, 202. |
【2】 King, F.D.; Bromidge, S.M.; Wyman, P.A. (SmithKline Beecham plc); Sulphonamide derivs., process for their preparation, and their use as medicaments. WO 9827081 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 11882 | 1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine | 35386-24-4 | C11H16N2O | 详情 | 详情 |
(II) | 25384 | 1-(2-methoxy-5-nitrophenyl)piperazine | C11H15N3O3 | 详情 | 详情 | |
(III) | 25385 | tert-butyl 4-(2-methoxy-5-nitrophenyl)-1-piperazinecarboxylate | C16H23N3O5 | 详情 | 详情 | |
(IV) | 25386 | tert-butyl 4-(5-amino-2-methoxyphenyl)-1-piperazinecarboxylate | C16H25N3O3 | 详情 | 详情 | |
(V) | 25387 | 5-chloro-3-methyl-1-benzothiophene-2-sulfonyl chloride | C9H6Cl2O2S2 | 详情 | 详情 | |
(VI) | 25388 | tert-butyl 4-(5-[[(5-chloro-3-methyl-1-benzothiophen-2-yl)sulfonyl]amino]-2-methoxyphenyl)-1-piperazinecarboxylate | C25H30ClN3O5S2 | 详情 | 详情 |
Extended Information